Bristol-Myers to Take a $3B Tax Hit in Q4 2017 Post author:Sam Post published:January 7, 2018 Post category:BioPharma The expense is primarily related to taxes on unremitted offshore earnings, the company said. Source: BioSpace You Might Also Like PharmaCyte Presents Options for Phase II Pancreatic Cancer Trial February 27, 2018 Doing it Right: The Man Who Blew Up Theranos Started His Own Medical Testing Biotech October 3, 2017 BASi Names Senior Vice President Of Preclinical Services March 8, 2017